Now that Prostate Cancer Awareness Month has ended, Mercy Health is urging men to take a closer look at what they really know ...

Patients who receive guideline-concordant treatment for nonmetastatic prostate cancer are more likely to die from other causes. Men with nonmetastatic prostate cancer (PCa) who receive treatment ...

Men who improve their adherence to ACS guidelines following diagnosis have a reduction in all-cause and cardiovascular mortality compared to those who maintain a low concordance with guideline ...

"Whether the modest trend in biochemical failure differences will sustain and translate into prostate cancer-specific or ...

Symptomless’ man diagnosed with prostate cancer after heeding ‘gut feeling’ - Jason Yeo was shocked as he was otherwise ...

An army of scientists, oncologists, policymakers and advocates has called for urgent reforms to stem Africa’s prostate cancer crisis. They said prostate cancer has become the leading health risk among ...

Prostate Cancer is one of the leading causes of cancer-related deaths in men. For Prostate Cancer Awareness month, Mosaic ...

To quantify second primary malignancy-related deaths, researchers analyzed data from the US Centers for Disease Control and Prevention’s WONDER database.

A family history of prostate cancer has long been one of the few universally accepted risk factors for the disease. New findings now provide evidence that risk stratification based on family history ...

ORLANDO—Statin use is associated with a nearly two thirds reduced risk of death from prostate cancer, a study found. The finding is based on a study of 760 New Jersey men—380 cases (men aged 55-79 who ...

Among patients with grade group 1 prostate cancer, those belonging to higher risk groups were more likely to have adverse pathology and die from their disease. About 1 in 6 patients with grade group 1 ...

Given its success, Prostate Cancer Real Talk podcast attracted a couple of pharmaceutical sponsors — namely Pfizer and Novartis.